Pamela De Moor MS, PhD Vir Biotechnology, Inc

Pamela De Moor, MS/PhD is currently a Senior Director of Formulations and Drug Product at Vir Biotechnology and has been working at Vir for the past 2 years. She has been in the industry for 30 years and has worked on many modalities with focus on live attenuated virus, vaccines, and not least monoclonal antibodies. Pam is also an experienced process engineer with in-depth and hands on experience with all drug product processes. Pam has worked internationally spending 6 years in Novartis in Switzerland where she ran the Late-Stage Biologics group. Pam is a chemical engineer who graduated from California Institute of Technology and completed her MS/PhD from a joint Bioengineering program at UC San Francisco and UC Berkeley. From there she went on to modified atmosphere packaging, inhalation technology, drug delivery systems, and finally biopharmaceutics. She is very excited to share the experiences of developing a unique therapeutic for COVID-19 at a pandemic pace.